AVAHO

Real-world survival benefit with CDK4/6 inhibitors in MBC

February 24, 2023

Breast Cancer

Advanced imaging technology could help predict lung cancer progression after surgery

February 24, 2023

Postop RT: Meaningful survival improvement in N2 lung cancer

February 24, 2023

Lung Cancer

Could your patients benefit? New trials in lung cancer

February 22, 2023

Lung Cancer

Talazoparib add-on improves outcomes in metastatic prostate cancer

February 22, 2023

Adjuvant nivolumab as standard of care in resected bladder cancer

February 22, 2023

Genitourinary Cancer

Oncologist stars in film and shares philosophy on death

February 22, 2023

Maternal infection in pregnancy ups risk for childhood leukemia?

February 22, 2023

CML: Preventing chemo-induced vascular toxicity

February 21, 2023

New cancer screen, same issues: Physicians confront Galleri test

February 21, 2023

‘Financial toxicity’ from breast cancer is a worldwide phenomenon

February 21, 2023

Expert discusses pros, cons of molecular tests for melanoma

February 21, 2023

Progress in breast cancer screening over the past 50 years: A remarkable story, but still work to do

February 19, 2023

Breast Cancer

Rucaparib benefit in BRCA+ prostate cancer confirmed

February 17, 2023

Transplant vs. chemo: Similar AML survival rates

February 17, 2023

AML